Log In
Sunday 24th June 2018

Hope for rheumatiod arthritis sufferers

2nd July 2010

Rheumatoid arthritis patients look set to benefit from a new drug following a change of mind by the National Institute for Health and Clinical Excellence.

The NHS rationing watchdog had initially planned to ban the treatment RoActerma, despite the fact it is prescribed to patients in Scotland as well as those in most other European countries but has now published draft guidance recommending the treatment, bringing hope to the 37,000 sufferers of rheumatoid arthritis who cannot be helped by the drugs available.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018